Company ProfileAproxy is a NUS spin-off working on point-of-care testing platform. Our goal is to bring lab quality diagnostics closer to the patient with our patented single-step immunoassay test. Our core technology lies in an unique molecular switch design which can readily be adapted for different biomarkers. The focus area is on probing one's immune health such as allergy testing via blood IgE quantification.We are looking for partners with expertise in device fabrication to co-develop a test cartridge compatible with our single-step assay workflow.